BBNX
Beta Bionics, Inc.
NASDAQ · USHealthcareMedical - Equipment & Services
$17.08-1.21%
Price as of Jul 20, 2026
BBNX ownership
Beta Bionics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
16
Net (3m)
-$937.0K
Insider trades by month Buys Sells
Dec
Jan
Mar
May
Jun
Jul
Context3-month price +33.9%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 2, 2026 | Feider Stephenofficer: Chief Financial Officer | Option | 5,104 | $5.10 |
| Jul 2, 2026 | Feider Stephenofficer: Chief Financial Officer | Sell | 4,896 | $17.03 |
| Jul 2, 2026 | Feider Stephenofficer: Chief Financial Officer | Option | 4,896 | $5.10 |
| Jul 2, 2026 | Feider Stephenofficer: Chief Financial Officer | Sell | 5,104 | $17.05 |
| Jun 30, 2026 | Feider Stephenofficer: Chief Financial Officer | Sell | 5,104 | $17.05 |
| Jun 30, 2026 | Feider Stephenofficer: Chief Financial Officer | Sell | 4,896 | $17.03 |
| Jun 30, 2026 | Feider Stephenofficer: Chief Financial Officer | Option | 4,896 | $5.10 |
| Jun 30, 2026 | Feider Stephenofficer: Chief Financial Officer | Option | 4,982 | $5.10 |
| Jun 25, 2026 | Hopman Markofficer: Chief Commercial Officer | Sell | 1,258 | $15.01 |
| Jun 25, 2026 | Jones Christydirector | Sell | 1,406 | $15.00 |
| Jun 5, 2026 | Jones Christydirector | Sell | 2,811 | $14.00 |
| Jun 5, 2026 | Hopman Markofficer: Chief Commercial Officer | Sell | 275 | $12.31 |
| Jun 3, 2026 | Feider Stephenofficer: Chief Financial Officer | Sell | 6,676 | $12.61 |
| Jun 3, 2026 | Mensinger Mikeofficer: Chief Product Officer | Sell | 4,378 | $12.61 |
| Jun 3, 2026 | Hopman Markofficer: Chief Commercial Officer | Sell | 5,329 | $12.61 |
| Jun 3, 2026 | Russell Steven Jonofficer: Chief Medical Officer | Sell | 4,222 | $12.61 |
| Jun 3, 2026 | Saint Seandirector, officer: President & CEO | Sell | 16,872 | $12.61 |
| May 26, 2026 | Dearen Danny L.director | Grant | 16,965 | — |
| May 26, 2026 | Lezack Adamdirector | Grant | 16,965 | — |
| May 26, 2026 | Lezack Adamdirector | Sell | 1,000 | $9.95 |
| May 26, 2026 | CARNEY SEANdirector | Grant | 16,965 | — |
| May 26, 2026 | MICHEL GERARD Jdirector | Grant | 16,965 | — |
| May 26, 2026 | Jones Christydirector | Sell | 1,998 | $9.95 |
| May 26, 2026 | Jones Christydirector | Grant | 16,965 | — |
| May 26, 2026 | Palasis Mariadirector | Grant | 16,965 | — |
| May 26, 2026 | Lezack Adamdirector | Sell | 998 | $11.21 |
| Mar 16, 2026 | Russell Steven Jonofficer: Chief Medical Officer | Sell | 1,025 | $29.34 |
| Mar 16, 2026 | Hopman Markofficer: Chief Commercial Officer | Sell | 2,061 | $30.66 |
| Mar 16, 2026 | Hopman Markofficer: Chief Commercial Officer | Sell | 856 | $29.34 |
| Mar 13, 2026 | Russell Steven Jonofficer: Chief Medical Officer | Grant | 91,520 | $12.63 |
Source: BBNX SEC Form 4 filings, latest Jul 2, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their BBNX positions over the last 6 months (SEC Form 13F).
Increased
115
New positions
66
Reduced
82
Sold out
63
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 5.9M | May 15, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 5.0M | Feb 13, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Increased | 4.4M | May 14, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Unchanged | 4.3M | Feb 17, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 4.3M | Feb 17, 2026 |
| MORGAN STANLEY | Reduced | 4.2M | May 15, 2026 |
| SANDS CAPITAL VENTURES, LLC | Increased | 3.7M | May 8, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 3.6M | May 15, 2026 |
| SANDS CAPITAL VENTURES, LLC | Unchanged | 3.6M | Feb 13, 2026 |
| MORGAN STANLEY | Reduced | 3.5M | Feb 13, 2026 |
| BLACKROCK, INC. | Increased | 3.0M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 2.9M | Feb 12, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Reduced | 2.5M | Feb 12, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Increased | 2.5M | May 15, 2026 |
| RTW INVESTMENTS, LP | Reduced | 2.5M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.